Adelanta tu networking para South Summit 2024 revisando nuestro marketplace, donde encontrarás los perfiles de todas las Startups, Colaboradores, Aceleradoras e Instituciones que participarán en el evento.
Busco una relación con una Trabajando en Que puedan colaborar con mi proyecto via
Management of neurodegenerative disease is hampered by the lack of objective measures and the infrequency of assessment. We believe “Every patient deserves an objective measurement for when they visit their doctor that is supplemental to the exam." nQ is a computational biotechnology company that captures digital phenotyping through AI-aided analysis of personal device interactions. It has developed digital biomarkers for Parkinson's disease in early and newly diagnosed/untreated stages of disease. In addition to PD, it is currently conducting a number of separate clinical trials to develop digital biomarkers individually relevant to Multiple Sclerosis, ALS, and Alzheimer's. nQ was awarded Breakthrough Status by the FDA in November 2019.
Si tienes una propuesta sobre algunas de las siguientes áreas, estaremos encantados de analizarlas: